Janssen PA - Search Results

1

The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.

Xhonneux R, Wouters L, Reneman RS, Janssen PA. Xhonneux R, et al. Among authors: janssen pa. Eur J Pharmacol. 1990 Jun 8;181(3):261-5. doi: 10.1016/0014-2999(90)90087-m. Eur J Pharmacol. 1990. PMID: 1974517

2

Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.

Van de Water A, Xhonneux R, Reneman RS, Janssen PA. Van de Water A, et al. Among authors: janssen pa. J Cardiovasc Pharmacol. 1992 Jul;20(1):18-24. J Cardiovasc Pharmacol. 1992. PMID: 1383627

3

Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

Van de Water A, Janssens W, Van Neuten J, Xhonneux R, De Cree J, Verhaegen H, Reneman RS, Janssen PA. Van de Water A, et al. Among authors: janssen pa. J Cardiovasc Pharmacol. 1988 May;11(5):552-63. doi: 10.1097/00005344-198805000-00007. J Cardiovasc Pharmacol. 1988. PMID: 2455841

4

Nebivolol is devoid of intrinsic sympathomimetic activity.

Janssens WJ, Van de Water A, Xhonneux R, Reneman RS, Van Nueten JM, Janssen PA. Janssens WJ, et al. Among authors: janssen pa. Eur J Pharmacol. 1989 Jan 2;159(1):89-95. doi: 10.1016/0014-2999(89)90047-2. Eur J Pharmacol. 1989. PMID: 2565239

5

Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.

Van de Water A, Xhonneux R, Reneman RS, Janssen PA. Van de Water A, et al. Among authors: janssen pa. Eur J Pharmacol. 1988 Oct 26;156(1):95-103. doi: 10.1016/0014-2999(88)90151-3. Eur J Pharmacol. 1988. PMID: 3208842

6

Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.

Van de Water A, d'Aubioul J, Van Gerven W, de Chaffoy de Courcelles D, Freyne E, Xhonneux R, Reneman RS, Janssen PA. Van de Water A, et al. Among authors: janssen pa. Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:60-74. Arch Int Pharmacodyn Ther. 1992. PMID: 1530374

7

5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

De Clerck F, Loots W, Somers Y, Beetens J, Wouters L, Wynants J, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Br J Pharmacol. 1990 Apr;99(4):631-6. doi: 10.1111/j.1476-5381.1990.tb12982.x. Br J Pharmacol. 1990. PMID: 2113823 Free PMC article.

8

Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.

Van Nueten JM, Janssens WJ, Xhonneux R, Janssen PA. Van Nueten JM, et al. Among authors: janssen pa. J Cardiovasc Pharmacol. 1988;11 Suppl 1:S10-5. J Cardiovasc Pharmacol. 1988. PMID: 2459506 Review.

9

Beta-adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol.

Pauwels PJ, Leysen JE, Janssen PA. Pauwels PJ, et al. Among authors: janssen pa. Eur J Pharmacol. 1989 Dec 5;172(6):471-9. doi: 10.1016/0922-4106(89)90030-8. Eur J Pharmacol. 1989. PMID: 2575531

10

Specific alpha-adrenoceptor blocking effect of droperidol on isolated smooth muscles.

van Nueten JM, Reneman RS, Janssen PA. van Nueten JM, et al. Among authors: janssen pa. Eur J Pharmacol. 1977 Jul 1;44(1):1-8. doi: 10.1016/0014-2999(77)90109-1. Eur J Pharmacol. 1977. PMID: 18356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters